TEM rises nearly 9% as robust revenue growth and bullish technical signals drive gains

Traders Union
All News
Stocks
Tempus AI surges 8.75% to $72.48 today

Highlights

Tempus AI reported quarterly revenue up 21.6% year-over-year to $382 million, with gross margin at 64% and net income positive.
Full-year revenue guidance rose to about $1.6 billion, the cash position exceeded $800 million, and the $1.5 billion Personalis acquisition followed Personalis technology being used in positive Merck and Moderna cancer vaccine trials.
Shares of Tempus AI are trading in a strong bullish trend near $72.48, with technicals overbought and a projected five-day range of $62.68 to $82.29.

Positive outlook boosted by revenue forecast hike and Personalis deal

Tempus AI announced a quarterly revenue increase of 21.6% year-over-year to approximately $382 million, with gross margin rising to 64% and net income turning positive. The company raised its full-year revenue guidance to about $1.6 billion and reported a cash position exceeding $800 million. Momentum was further driven by its $1.5 billion acquisition of Personalis, a genomic testing company, following positive Phase 3 mRNA cancer vaccine trial results from Merck and Moderna that utilized Personalis technology.

Anton Kharitonov, expert at Traders Union, views the recent Tempus AI surge as heavily driven by speculative buying after news of solid financials and a major acquisition. He notes the sharp move above all key moving averages but points to persistently overbought momentum indicators as a serious warning flag for bulls. Weakness remains in the longer-term moving average alignment, suggesting the underlying trend may not yet be fully supportive. The current valuation leaves little margin for error given the pace of recent news-driven gains. Kharitonov concludes, "Unless the stock can prove sustainable strength above $82.29, I expect a correction as investors reassess risk and digest gains."

Viktoras Karapetjanc, expert at Traders Union, highlights Tempus AI's strong revenue growth and positive net income as signs of accelerating fundamental momentum. He sees the $1.5 billion Personalis acquisition as a strategic move that reinforces Tempus AI's position in the expanding genomics market and capitalizes on breakthroughs in mRNA vaccine trials. Current financial strength, including a robust cash reserve, positions the business for further growth and innovation. Karapetjanc states, "The bullish structure remains intact, and with market confidence high, I expect further upside as the integration of Personalis unfolds."

Jainam Mehta, market strategist, notes that Tempus AI's technicals are solidly bullish with price well above major moving averages. However, he observes that overbought oscillator readings suggest the rally could soon pause or revert, in line with the high daily volatility. Mehta adds that a breakout above $82.29 could trigger another leg higher, but a sustained close below $70.73 would be a contrarian signal for short-term downside. He says, "Aggressive traders may seek breakout setups, but I would watch for a pullback to $70.73 as a potential tactical entry point."

Uptrend confirmed as buying strength faces overbought momentum risks

Tempus AI is trading above its 20-day, 50-day, and 200-day moving averages ($49.84, $52.2, and $56.86 respectively), reinforcing a bullish structure across short-, medium-, and long-term timeframes. This uptrend is further validated as the stock is holding well above the Ichimoku Kijun ($54.83, acting as support), with near-term boundaries now defined by a floor at $70.73 and a ceiling at $82.29. The longer-term alignment of the MA-50 vs MA-200 remains bearish. Momentum readings show sustained strength, with the MACD signaling buy and the ADX indicating neutral trend conviction. The RSI sits at 70.71, pointing to overbought conditions that are confirmed by Stochastic RSI, Commodity Channel Index, and Bull/Bear Power readings—all flagged as overbought. Bull/Bear Power at 14.51 confirms buyers are dominating intraday momentum, but the overbought signal implies a risk of short-term pauses or pullbacks. The Awesome Oscillator also supports ongoing bullish momentum. The stock is up sharply to $72.48, near its intraday high, with daily volatility at 8.40%. The bullish tone is confirmed by momentum signals, yet overbought readings caution against excessive chasing at current levels.

Previously it was reported that Tempus AI had confirmed a strong technical breakout, with analysts emphasizing the importance of maintaining upward momentum. The latest developments solidify this view with both operational and technical progress, while the overbought state signals that monitoring the $70.73 support and $82.29 resistance remains crucial for assessing near-term direction.

Source of Data: TEM Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.